Molecular diagnostics companies develop and supply technologies that detect disease-associated DNA, RNA and other defined molecular signatures in human clinical samples. Their products support infectious disease testing, genetic diagnosis, cancer profiling and precision medicine, from central laboratory workflows to rapid near-patient assays.
This category includes companies working on:
Browse 51 UK molecular diagnostics companies below.
Diagnostics, devices and diabetes care for global healthcare
Abbott Laboratories is a multinational healthcare company providing diagnostic instruments, reagents, and medical devices to hospitals, laboratories, and healthcare professionals. UK operations span commercial, R&D, and manufacturing functions across multiple sites. Core life science offerings include in vitro…
Non-endoscopic molecular diagnostics for early oesophageal cancer detection
Cyted Health is a gastrointestinal molecular diagnostics company developing minimally invasive testing for early detection and monitoring of oesophageal pre-cancer and cancer. Its platform combines a swallowable capsule sponge cell collection device with AI-driven biomarker molecular assays to detect Barrett's…
Mitochondrial DNA liquid biopsy tests for cancer and disease detection
MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers. Its technology detects specific mitochondrial DNA deletions in blood and tissue samples as indicators of disease, enabling non-invasive testing for conditions that are difficult to diagnose.…
Molecular diagnostic PCR, dPCR and NGS kits for clinical laboratories
TRUPCR Europe develops and supplies molecular diagnostic kits and reagents for clinical and research laboratories. Its portfolio includes real-time PCR, digital PCR and next-generation sequencing assays for oncology, haematological malignancies, infectious diseases and antimicrobial resistance. Products also include…
Clinical genomic decision support software for rare disease and oncology
Congenica is a clinical genomic interpretation platform spun out of the Wellcome Sanger Institute. Its software supports variant analysis and clinical reporting across rare disease, oncology and infectious disease, integrating whole genome sequencing data with phenotypic information to generate actionable diagnostic…
Integrated sample collection and rapid molecular diagnostic devices
ReadyGo Diagnostics develops disposable sample-collection and preparation devices for rapid diagnostic testing. Its technology combines swab collection and lysis chemistry in a single unit and is designed to work with lateral flow, molecular and immunoassay formats. It also supports rapid isothermal molecular tests…
3D genomics platform for blood-based clinical diagnostics and precision medicine
Oxford BioDynamics develops blood-based diagnostic tests and precision medicine tools using its proprietary 3D genomics platform. The technology analyses chromosome conformation to identify epigenomic biomarkers linked to disease, prognosis and treatment response. Commercial products include tests for immune…
PCR platform enabling precision diagnostics on standard lab instruments
Signatur Biosciences is a biotechnology company developing a molecular diagnostic platform that encodes complex RNA gene expression signatures into single qPCR reactions. The technology enables precision diagnostics to be performed on standard laboratory instruments already present in clinical settings, removing…
Clinical and laboratory diagnostics systems for the UK market
Roche Diagnostics is the UK diagnostics subsidiary of F. Hoffmann-La Roche, based in Burgess Hill, West Sussex. The company supplies high-throughput laboratory analysers, reagents, and diagnostic software to NHS hospitals, clinical laboratories, and research institutions across the UK. Its portfolio spans clinical…
Cancer genetics testing and contract research
Oncologica provides molecular cancer diagnostics and contract research services from its laboratory at Chesterford Research Park near Cambridge. Its Oncofocus testing uses tumour DNA profiling to help clinicians identify potentially relevant targeted treatments and immunotherapies. The company also develops…
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…
Multiplex PCR pathogen detection kits for infectious disease diagnostics
Genetic Signatures is a molecular diagnostics company supplying multiplex real-time PCR detection kits for infectious disease testing in hospital and pathology laboratories. Its proprietary technology simplifies genetic sequences to improve multiplex efficiency and increase resistance to pathogen mutation,…
Rapid light-based point-of-care diagnostics for infections and pathogens
ExGen Dx, previously Linear Diagnostics, is a University of Birmingham spin-out developing a portable, light-based diagnostic platform that detects multiple infections from a single sample without laboratory equipment. The technology combines a patented optical detection method with a room-temperature amplification…
Portable PCR diagnostics for high-consequence infectious diseases
BioGene develops portable real-time PCR instruments and diagnostic reagents for detecting infectious pathogens. Its extraction-free, freeze-dried chemistry is designed to detect pathogens directly from crude samples in under 30 minutes, reducing the need for conventional laboratory preparation. The company's assays…
Molecular diagnostic kits and genomic services for clinical laboratories
Yourgene Health is a molecular diagnostics company developing, manufacturing and commercialising IVD reagent kits and genomic services for reproductive health, precision medicine and infectious disease. Its product portfolio includes NGS-based non-invasive prenatal testing kits, cystic fibrosis screening assays,…
Plasmonic PCR diagnostics for rapid infectious disease detection
RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…
Portable PCR platform for decentralised genetic testing anywhere
Hyris is a biotechnology company developing a portable, IoT-integrated PCR platform for decentralised nucleic acid testing outside traditional laboratory settings. Its instrument runs proprietary assay cartridges and connects to a cloud-based software platform providing real-time results via a dedicated app. An open…
Preimplantation and prenatal genetic testing for reproductive medicine
Juno Genetics is a specialist reproductive genetics laboratory providing preimplantation genetic testing (PGT) services to IVF clinics in the UK and internationally. Using its proprietary next-generation sequencing platform, the company screens embryos for chromosomal abnormalities and single-gene disorders, and…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative PCR results directly from a dry swab in six to ten minutes with no sample preparation, targeting respiratory infections including influenza…
Molecular diagnostic assay development for oncology biomarkers
APIS Assay Technologies is a molecular diagnostics company developing and commercialising genomic assays for oncology and personalised medicine. The company combines an in-house biomarker research programme with contract assay development services, using PCR, digital PCR, and multi-omics platforms to translate…